Insider · CIK 0001213029
BRAWLEY OTIS W
Reports to the SEC for 5 companies · SOUTH SAN FRANCISCO, CA
Transactions
50
Companies
5
Filings
14
CIK
0001213029
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-10 | LYELLyell Immunopharma, Inc. · Option (right to buy)A Award | — |
| 2026-06-08 | INCYINCYTE CORPA Award | — |
| 2026-06-08 | INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award | — |
| 2026-03-19 | AAGILENT TECHNOLOGIES, INC.A Award | +$241K |
| 2026-03-19 | AAGILENT TECHNOLOGIES, INC.A Award | +$99.2K |
| 2026-01-12 | PDSBPDS Biotechnology Corp · Employee Stock Option (Right to Buy)A Award | — |
| 2025-06-11 | PDSBPDS Biotechnology Corp · Employee Stock Option (Right to Buy)A Award | — |
| 2025-06-10 | INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award | — |
| 2025-06-10 | INCYINCYTE CORPA Award | — |
| 2025-05-15 | LYELLyell Immunopharma, Inc. · Option (right to buy)A Award | — |
| 2025-03-31 | LYELLyell Immunopharma, Inc.P Purchase | +$20K |
| 2025-03-14 | AAGILENT TECHNOLOGIES, INC.A Award | +$98.4K |
| 2025-03-14 | AAGILENT TECHNOLOGIES, INC.A Award | +$220K |
| 2024-06-24 | PDSBPDS Biotechnology Corp · Employee Stock Option (Right to Buy)A Award | — |
| 2024-06-14 | LYELLyell Immunopharma, Inc. · Option (right to buy)A Award | — |
| 2024-06-12 | INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award | — |
| 2024-06-12 | INCYINCYTE CORPA Award | — |
| 2024-03-15 | AAGILENT TECHNOLOGIES, INC.A Award | +$247K |
| 2024-03-15 | AAGILENT TECHNOLOGIES, INC.A Award | +$111K |
| 2023-09-08 | LYELLyell Immunopharma, Inc. · Option (right to buy)A Award | — |
| 2023-07-14 | PDSBPDS Biotechnology Corp · Employee Stock Option (Right to Buy)A Award | — |
| 2023-06-16 | LYELLyell Immunopharma, Inc. · Option (right to buy)A Award | — |
| 2023-06-14 | INCYINCYTE CORPA Award | — |
| 2023-06-14 | INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award | — |
| 2023-03-16 | AAGILENT TECHNOLOGIES, INC.A Award | +$101K |
| 2023-03-16 | AAGILENT TECHNOLOGIES, INC.A Award | +$227K |
| 2022-06-28 | PDSBPDS Biotechnology Corp · Stock Option (Right to Buy)A Award | — |
| 2022-06-15 | INCYINCYTE CORPA Award | — |
| 2022-06-15 | INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award | — |
| 2022-06-08 | LYELLyell Immunopharma, Inc. · Option (right to buy)A Award | — |
| 2022-03-17 | AAGILENT TECHNOLOGIES, INC.A Award | +$244K |
| 2022-03-17 | AAGILENT TECHNOLOGIES, INC.A Award | +$109K |
| 2021-11-18 | AAGILENT TECHNOLOGIES, INC.A Award | +$29K |
| 2021-11-18 | AAGILENT TECHNOLOGIES, INC.A Award | +$65.5K |
| 2021-09-27 | INCYINCYTE CORPA Award | — |
| 2021-09-27 | INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award | — |
| 2021-06-17 | PDSBPDS Biotechnology Corp · Stock Option (Right to Buy)A Award | — |
| 2020-11-03 | PDSBPDS Biotechnology Corp · Stock Option (Right to Buy)A Award | — |
| 2005-01-26 | THERAGENICS CORPM Exercise/Conversion | +$42.3K |
| 2005-01-26 | THERAGENICS CORPF Tax Payment | −$42.9K |
| 2005-01-26 | THERAGENICS CORPEmployee stock option (right to buy)M Exercise/Conversion | — |
| 2004-02-06 | THERAGENICS CORPF Tax Payment | −$11.2K |
| 2004-02-06 | THERAGENICS CORPF Tax Payment | −$5,580 |
| 2004-02-06 | THERAGENICS CORPF Tax Payment | −$2,204 |
| 2004-02-06 | THERAGENICS CORPF Tax Payment | −$3,330 |
| 2004-02-06 | THERAGENICS CORPF Tax Payment | −$5,620 |
| 2004-02-06 | THERAGENICS CORPM Exercise/Conversion | +$29.3K |
| 2004-02-06 | THERAGENICS CORPF Tax Payment | −$10.6K |
| 2004-02-06 | THERAGENICS CORPF Tax Payment | −$4,230.75 |
| 2004-02-06 | THERAGENICS CORPF Tax Payment | −$5,604 |
Recent filings
- 4BRAWLEY OTIS W0001213029-26-000007SEC(opens sec.gov)
- 4BRAWLEY OTIS W0001213029-26-000005SEC(opens sec.gov)
- 4BRAWLEY OTIS W0001090872-26-000037SEC(opens sec.gov)
- 4BRAWLEY OTIS W0001140361-26-007640SEC(opens sec.gov)
- 4BRAWLEY OTIS W0001628280-25-031014SEC(opens sec.gov)
- 4BRAWLEY OTIS W0001140361-25-022227SEC(opens sec.gov)
- 4BRAWLEY OTIS W0001415889-25-013710SEC(opens sec.gov)
- 4BRAWLEY OTIS W0001415889-25-009604SEC(opens sec.gov)
- 4BRAWLEY OTIS W0001127602-25-009720SEC(opens sec.gov)
- 4BRAWLEY OTIS W0001140361-24-031290SEC(opens sec.gov)
- 4BRAWLEY OTIS W0001415889-24-017147SEC(opens sec.gov)
- 4BRAWLEY OTIS W0000879169-24-000094SEC(opens sec.gov)
- 4BRAWLEY OTIS W0001127602-24-010681SEC(opens sec.gov)
- 4BRAWLEY OTIS W0001209191-23-048782SEC(opens sec.gov)
Companies
Address
C/O LYELL IMMUNOPHARMA, INC. 201 HASKINS WAY, SUITE 101
SOUTH SAN FRANCISCO, CA, 94080